Lanthanum Carbonate Nanosheets Based Colloidal Hydrogel for Modulating Innate & Adaptive Tumor Immunotherapy by Augmented Cellular Pyroptosis
Advanced Science · 2026
DOI: 10.1002/advs.76966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yang Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Zhengzhou Advanced Research Institute of Harbin Institute of Technology, Zhengzhou, China. Hauptthemen laut MEDLINE: Pyroptosis, Lanthanum, Immunotherapy, Hydrogels. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Province Zhongyuan Leading Talent Project.
Abstract (Originalsprache)
Cellular pyroptosis, a pro‐inflammatory form of programmed cell death, emerges as a promising strategy for cancer immunotherapy. However, gene methylation hampers the expression of gasdermin E (GSDME), a pivotal protein in the caspase‐3‐mediated pyroptosis pathway, across numerous malignancies, including triple‐negative breast cancer (TNBC). This study elucidated that a colloidal hydrogel (GDLC hydrogel) loaded with decitabine (DAC) and crosslinked with lanthanum carbonate nanosheets (LCNSs) and gelatin nanoparticles (Gela NPs) could instigate pyroptosis in TNBC cells, specifically 4T1 cells. Within the tumor microenvironment (TME), the synergistic interaction between DAC and La 3+ reversed the epigenetic silencing of the GSDME gene, while concurrently activating caspase‐3, thus facilitating pyroptosis induction. Although monotherapy with La 3+ ‐induced apoptosis proved insufficient in tumor suppression, the concurrent inhibition of methyltransferase via DAC markedly suppressed both primary and recurrent tumors. Moreover, the combinatory application of the GDLC hydrogel and immune checkpoint inhibitors effectively neutralized the immunosuppressive TME of TNBC, triggered an anti‐tumor immune response and engendered a sustained immune memory effect. This strategy significantly curtailed tumor recurrence and metastasis, consequently improving the survival rates of mice in the 4T1 tumor‐bearing mouse model. In conclusion, this colloidal hydrogel platform introduced an innovative paradigm for the immunotherapy of triple‐negative breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Health, Zhengzhou Advanced Research Institute of Harbin Institute of Technology, Zhengzhou, China.
- School of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
- School of Biomedical Engineering, Anhui Medical University, Hefei, China.
ORCID-Profile: Yang Hong, Haitao Wu, Weitao Wang, Yaoyu Hu, Zhengbao Zha
Förderung
- National Natural Science Foundation of China
- Henan Province Zhongyuan Leading Talent Project
Zitieren
APA
Hong, Y., Wu, H., Wang, W., Zhang, X., Chen, Q., Hu, Y., & Zha, Z. (2026). Lanthanum Carbonate Nanosheets Based Colloidal Hydrogel for Modulating Innate & Adaptive Tumor Immunotherapy by Augmented Cellular Pyroptosis. Advanced Science. https://doi.org/10.1002/advs.76966
Vancouver
Hong Y, Wu H, Wang W, Zhang X, Chen Q, Hu Y, et al. Lanthanum Carbonate Nanosheets Based Colloidal Hydrogel for Modulating Innate & Adaptive Tumor Immunotherapy by Augmented Cellular Pyroptosis. Advanced Science. 2026. doi:10.1002/advs.76966
BibTeX
@article{Hong2026,
author = {Hong, Yang and Wu, Haitao and Wang, Weitao and Zhang, Xuan and Chen, Qian and Hu, Yaoyu and Zha, Zhengbao},
title = {Lanthanum Carbonate Nanosheets Based Colloidal Hydrogel for Modulating Innate & Adaptive Tumor Immunotherapy by Augmented Cellular Pyroptosis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76966}
}
EUVIMED